Related Experiment Video
Updated: May 2, 2026
06:54
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
5.3K
Hereditary angioedema with normal C1-INH (HAE type III)
1Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, Calif.
The Journal of Allergy and Clinical Immunology. in Practice
|February 26, 2014
Summary
Hereditary angioedema with normal C1 inhibitor (HAE type III) affects women predominantly and involves facial swelling. Its exact cause is unknown, but it may involve bradykinin pathway issues.
Area of Science:
- Immunology
- Genetics
Background:
- Hereditary angioedema with normal C1 inhibitor (HAE type III) is a rare genetic disorder.
- It causes unpredictable swelling episodes, similar to C1-INH deficiency types, but with distinct clinical features.
Purpose of the Study:
- To review the clinical presentation, pathophysiology, and diagnostic challenges of HAE with normal C1 inhibitor.
- To discuss current understanding and potential therapeutic approaches.
Main Methods:
- Literature review of existing studies on HAE with normal C1 inhibitor.
- Analysis of clinical features, genetic associations, and treatment outcomes.
Main Results:
- HAE with normal C1 inhibitor predominantly affects women, often exacerbated by estrogen.
- Facial and oropharyngeal angioedema are common.
- Pathophysiology is unclear, but bradykinin pathway involvement is suspected.
- Diagnosis relies on clinical criteria due to lack of specific tests.
- Factor XII mutations are found in a minority of patients.
Conclusions:
- HAE with normal C1 inhibitor presents unique clinical characteristics.
- Further research is needed to elucidate the pathophysiology and develop diagnostic tools.
- Current treatments for C1-INH deficiency may offer benefits, but controlled studies are lacking.
Related Concept Videos
01:19Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:22Cerebral Edema ll: Pathophysiology
19
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
01:19Cerebral Edema l: Introduction
30
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
30
01:31Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
01:26Aneurysm III: Interprofessional Care
478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478